Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01140282 · ClinicalTrials.gov registry record · NA
Exercise Program for Early Breast Cancer Survivors
A NA study, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 106
- Enrollment target
NCT01140282 is a NA study that has completed, run by University of Southern California. The registered enrollment target is 106 participants.
The verdict
NCT01140282, a NA study, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 106 participants
- Enrollment target
Study Summary
Rationale: Exercise therapy may improve the quality of life of breast cancer survivors. Purpose: This randomized clinical trial studies exercise therapy and quality of life in postmenopausal early breast cancer survivors receiving aromatase inhibitor therapy.
Interventions
- OTHER questionnaire administration
- PROCEDURE quality-of-life assessment
- BEHAVIORAL exercise intervention
- PROCEDURE management of therapy complications
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2012-05-21 |
| Est. Completion | 2018-10-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01140282
The ClinicalTrials.gov registry entry for NCT01140282 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 106 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which questionnaire administration is the first listed.
NCT01140282 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01140282 about?
NCT01140282 is a clinical study titled "Exercise Program for Early Breast Cancer Survivors". Rationale: Exercise therapy may improve the quality of life of breast cancer survivors. Purpose: This randomized clinical trial studies exercise therapy and quality of life in postmenopausal early breast cancer survivors receiving aromatase inhibitor therapy.
What is the current status of trial NCT01140282?
This trial is currently completed. It is a NA study. The enrollment target is 106 participants. The study started on 2012-05-21. Estimated completion is 2018-10-01.
What interventions are being tested in trial NCT01140282?
The interventions under investigation include: questionnaire administration (OTHER), quality-of-life assessment (PROCEDURE), exercise intervention (BEHAVIORAL), management of therapy complications (PROCEDURE).
Who is sponsoring clinical trial NCT01140282?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.